FIELD: biotechnology.
SUBSTANCE: present invention relates to biotechnology, particularly to a novel method of producing polypeptides. Invention discloses a method for liquid-phase synthesis of polypeptides by successive elongation of a second terminal portion (primary or secondary amino group, hydroxy group or mercapto group) of a peptide chain with links, characterized in that the links are selected from a group consisting of α-, β- or γ-amino acids, α-, β- or γ-hydroxy acids, α-, β- or γ-mercapto acids (natural or non-natural or synthetic), molecules of which contain at least two functional groups.
EFFECT: disclosed is a method of producing peptides or proteins or peptidomimetics.
12 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
THERAPEUTIC PEPTIDES | 2010 |
|
RU2548905C2 |
THERAPEUTIC PEPTIDES | 2010 |
|
RU2676713C2 |
NOVEL ANALOGUES OF GLUCAGON-LIKE PEPTIDE, COMPOSITION AND METHOD OF USE | 2010 |
|
RU2557301C2 |
PEPTIDES MARKED WITH RADIOACTIVE ISOTOPES FOR DIAGNOSING AND TREATING DISEASES | 1996 |
|
RU2171117C2 |
PEPTIDOMIMETIC MACROCYCLES AND THEIR APPLICATION | 2012 |
|
RU2639523C2 |
ANTIBIOTIC PEPTIDES | 2008 |
|
RU2472805C2 |
APOPTOSIS INHIBITORS AND USE THEREOF | 2011 |
|
RU2582247C2 |
RGD-CONTAINING PEPTIDOMIMETICS AND THEIR APPLICATION | 2009 |
|
RU2519736C2 |
AMATOXIN-CONJUGATES WITH IMPROVED LINKERS | 2011 |
|
RU2601411C2 |
CYTOKINE CONJUGATES FOR TREATMENT OF AUTOIMMUNE DISEASES | 2018 |
|
RU2787201C2 |
Authors
Dates
2024-10-07—Published
2020-05-04—Filed